• NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates apply.
• Human-Animal Interaction (HAI) Research (R03 - Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): March 30, 2018, March 30, 2019.
• Human-Animal Interaction (HAI) Research (R21 - Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): March 30, 2018, March 30, 2019.
• Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)
National Institute on Aging
Application Receipt/Submission Date(s): March 27, 2018; February 20, 2019; and February 20, 2020.
• Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional)
National Institute on Aging
Application Receipt/Submission Date(s): April 10, 2018, January 8, 2019, and January 8, 2020.
• Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional)
National Institute on Aging
Application Receipt/Submission Date(s): April 10, 2018, January 8, 2019, and January 8, 2020.
• Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)
National Institute on Aging
Application Receipt Date(s): April 10, 2018.
• NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date(s): March 27, 2018; July 2, 2018; November 2, 2018; March 4, 2019; July 2, 2019; November 4, 2019; March 3, 2020, July 2, 2020, November 3, 2020.
• Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date(s): March 27, 2018, July 2, 2018; November 2, 2018, March 4, 2019, July 2, 2019; November 4, 2019 March 3, 2020, July 2, 2020, November 3, 2020.
• Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates apply.
• Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates apply.
• Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date(s): July 2, 2018; November 2, 2018, March 4, 2019, July 2, 2019; November 4, 2019 March 3, 2020, July 2, 2020, November 3, 2020.
• High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
National Institutes of Health
National Institute of General Medical Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date(s): May 31, 2018.
• Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
National Institutes of Health
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date(s): May 31, 2018.
• Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
National Institutes of Health
National Institute of General Medical Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date(s): May 31, 2018.
• Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
National Cancer Institute
Application Receipt/Submission Date(s): April 11, 2018; October 10, 2018; April 11, 2019.
• Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
National Cancer Institute
Application Receipt/Submission Date(s): April 11, 2018; October 10, 2018; April 11, 2019.